James Wang
About James Wang
James Wang is an Applied Machine Learning Engineer currently working at Snorkel AI. He has a background in computer science from Columbia University and has held various roles in machine learning and research at organizations such as the U.S. Securities and Exchange Commission and Atlassian.
Work at Snorkel AI
James Wang has been employed at Snorkel AI as an Applied Machine Learning Engineer since 2024. He works in a hybrid capacity from New York, New York. His role involves applying machine learning techniques to enhance data labeling processes and improve AI model performance.
Previous Experience at U.S. Securities and Exchange Commission
In 2019, James Wang worked as a Quantitative Analyst at the U.S. Securities and Exchange Commission for a duration of three months. This position was based in New York, New York, where he contributed to quantitative analysis within the regulatory framework.
Experience at Atlassian
James Wang served as a Machine Learning Engineer in the Central AI team at Atlassian from 2022 to 2024. His work focused on developing machine learning solutions to improve product functionalities and user experience while based in New York, New York.
Educational Background at Columbia University
James Wang studied Computer Science at Columbia University, where he earned a Bachelor of Science (BS) degree from 2018 to 2022. He further pursued a Master of Science (MS) in Computer Science, completing the program in 2022. His education provided a strong foundation in computational theory and practical applications.
Teaching and Research Roles at Columbia University
During his time at Columbia University, James Wang held multiple roles. He was a Head Teaching Assistant from 2020 to 2022, where he supported undergraduate courses. Additionally, he worked as a Research Assistant from 2019 to 2022, contributing to various research projects in the field of computer science.
Research Assistant Role at Memorial Sloan Kettering Cancer Center
James Wang worked as a Research Assistant at Memorial Sloan Kettering Cancer Center from 2019 to 2021. In this role, he engaged in research activities that contributed to advancements in cancer treatment and patient care.